UBS Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.7M | Buy |
117,779
+15,138
| +15% | +$7.23M | 0.01% | 1433 |
|
|
2025
Q4 | $59.8M | Sell |
102,641
-114,702
| -53% | -$58.6M | 0.01% | 1443 |
|
|
2025
Q3 | $99.7M | Sell |
217,343
-288,371
| -57% | -$108M | 0.02% | 1031 |
|
|
2025
Q2 | $153M | Buy |
505,714
+184,207
| +57% | +$54.9M | 0.03% | 677 |
|
|
2025
Q1 | $106M | Sell |
321,507
-3,767
| -1% | -$1.24M | 0.02% | 877 |
|
|
2024
Q4 | $100M | Buy |
325,274
+144,644
| +80% | +$40.7M | 0.02% | 922 |
|
|
2024
Q3 | $38.3M | Buy |
180,630
+7,390
| +4% | +$1.89M | 0.01% | 1350 |
|
|
2024
Q2 | $48.5M | Buy |
173,240
+47,825
| +38% | +$11.4M | 0.01% | 1052 |
|
|
2024
Q1 | $33.5M | Buy |
125,415
+37,038
| +42% | +$8.73M | 0.01% | 1314 |
|
|
2023
Q4 | $20.4M | Buy |
88,377
+32,192
| +57% | +$5.63M | 0.01% | 1568 |
|
|
2023
Q3 | $8.21M | Buy |
56,185
+32,960
| +142% | +$6.2M | ﹤0.01% | 2138 |
|
|
2023
Q2 | $5.36M | Sell |
23,225
-7,698
| -25% | -$2.08M | ﹤0.01% | 2511 |
|
|
2023
Q1 | $7.49M | Sell |
30,923
-65,767
| -68% | -$17.9M | ﹤0.01% | 2147 |
|
|
2022
Q4 | $28.1M | Buy |
96,690
+71,227
| +280% | +$6.97M | 0.01% | 1184 |
|
|
2022
Q3 | $1.66M | Buy |
25,463
+7,278
| +40% | +$506K | ﹤0.01% | 3322 |
|
|
2022
Q2 | $1.3M | Sell |
18,185
-11,544
| -39% | -$849K | ﹤0.01% | 3499 |
|
|
2022
Q1 | $2.92M | Buy |
29,729
+7,597
| +34% | +$641K | ﹤0.01% | 3078 |
|
|
2021
Q4 | $1.88M | Buy |
22,132
+518
| +2% | +$42.6K | ﹤0.01% | 3791 |
|
|
2021
Q3 | $1.73M | Buy |
21,614
+15,536
| +256% | +$1.34M | ﹤0.01% | 3701 |
|
|
2021
Q2 | $592K | Sell |
6,078
-10,540
| -63% | -$1.25M | ﹤0.01% | 4604 |
|
|
2021
Q1 | $1.94M | Buy |
16,618
+14,212
| +591% | +$1.66M | ﹤0.01% | 3590 |
|
|
2020
Q4 | $267K | Sell |
2,406
-155
| -6% | -$18.9K | ﹤0.01% | 5051 |
|
|
2020
Q3 | $304K | Buy |
2,561
+72
| +3% | +$7.82K | ﹤0.01% | 4538 |
|
|
2020
Q2 | $282K | Sell |
2,489
-7,099
| -74% | -$698K | ﹤0.01% | 4556 |
|
|
2020
Q1 | $640K | Buy |
9,588
+8,509
| +789% | +$709K | ﹤0.01% | 3744 |
|
|
2019
Q4 | $99K | Sell |
1,079
-23,511
| -96% | -$2.28M | ﹤0.01% | 6016 |
|
|
2019
Q3 | $2.12M | Buy |
24,590
+13,464
| +121% | +$1.26M | ﹤0.01% | 3229 |
|
|
2019
Q2 | $1.17M | Buy |
11,126
+1,548
| +16% | +$166K | ﹤0.01% | 3627 |
|
|
2019
Q1 | $1.2M | Buy |
9,578
+3,645
| +61% | +$453K | ﹤0.01% | 3432 |
|
|
2018
Q4 | $669K | Sell |
5,933
-1,702
| -22% | -$263K | ﹤0.01% | 4033 |
|
|
2018
Q3 | $1.64M | Sell |
7,635
-1,130
| -13% | -$284K | ﹤0.01% | 3393 |
|
|
2018
Q2 | $2.45M | Sell |
8,765
-29,713
| -77% | -$5.22M | ﹤0.01% | 2988 |
|
|
2018
Q1 | $4.49M | Buy |
38,478
+38,291
| +20,476% | +$4.73M | ﹤0.01% | 2411 |
|
|
2017
Q4 | $17K | Sell |
187
-844
| -82% | -$48.2K | ﹤0.01% | 6678 |
|
|
2017
Q3 | $46K | Buy |
+1,031
| New | +$19.3K | ﹤0.01% | 5851 |
|
|
2017
Q2 | – | Sell |
-1,860
| Closed | -$29K | – | 7853 |
|
|
2017
Q1 | $29K | Buy |
1,860
+893
| +92% | +$14K | ﹤0.01% | 5886 |
|
|
2016
Q4 | $14K | Buy |
967
+825
| +581% | +$13.3K | ﹤0.01% | 6726 |
|
|
2016
Q3 | $2K | Sell |
142
-413
| -74% | -$4K | ﹤0.01% | 7408 |
|
|
2016
Q2 | $5K | Buy |
555
+295
| +113% | +$3.54K | ﹤0.01% | 7124 |
|
|
2016
Q1 | $2K | Sell |
260
-368
| -59% | -$3.07K | ﹤0.01% | 7315 |
|
|
2015
Q4 | $7K | Buy |
628
+362
| +136% | +$9.93K | ﹤0.01% | 7516 |
|
|
2015
Q3 | $16K | Buy |
266
+69
| +35% | +$4.98K | ﹤0.01% | 6905 |
|
|
2015
Q2 | $15K | Sell |
197
-26
| -12% | -$2.18K | ﹤0.01% | 7136 |
|
|
2015
Q1 | $15K | Sell |
223
-408
| -65% | -$35K | ﹤0.01% | 7286 |
|
|
2014
Q4 | $59K | Buy |
+631
| New | +$65.2K | ﹤0.01% | 6277 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
